Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2025 | Story Precious Shamase | Photo Supplied
Sanelisiwe Khumalo
Sanelisiwe Khumalo, the newly elected member of African Union Student Parliament.

The University of the Free State (UFS) Qwaqwa Campus is radiating with pride as Sociology master's student, Sanelisiwe Khumalo, has been elected to the prestigious African Union Student Parliament (AUSP). This achievement highlights the exceptional calibre of students nurtured within the institution, demonstrating their potential to effect significant change on a continental scale.

 

African Union Student Parliament welcomes UFS representative

Khumalo's election is testament to her academic excellence, unwavering leadership, and profound dedication to student representation. As a student in the Department of Sociology, she has consistently displayed a keen understanding of complex social issues and a fervent passion for driving positive change.

The AUSP serves as a vital platform for student voices across Africa, providing a space for young leaders to engage in meaningful dialogue, advocate for student rights, and contribute to shaping higher education policies. Khumalo's presence in this esteemed body will undoubtedly bring invaluable perspectives, representing the interests of UFS students with distinction.

"Congratulations, Sanelisiwe Khumalo, on your remarkable achievement," remarked Divane Nzima, Senior Lecturer and Subject Head of the Department of Sociology in the Faculty of The Humanities. "Being elected to the African Union Student Parliament is an indication of your dedication to contributing towards positive social change. As a Sociology master’s student at the University of the Free State, you have made us immensely proud. We wish you strength and wisdom to inspire change across the continent."

 

UFS sociology student inspires change on continental stage

Khumalo’s journey is a shining example of the transformative power of education and the boundless opportunities available to students on the UFS Qwaqwa Campus. Her success story embodies the university’s commitment to fostering a supportive and empowering environment where students can thrive and reach their full potential, aligning with the UFS’ Vision 130 as a student-centred institution focused on excellence and impact.

Adding to her impressive journey, Khumalo participated in an enriching exchange programme at the University of Education Freiburg in Germany last year. This collaboration, formalised through a Memorandum of Understanding (MoU), has opened doors for students, staff, and faculty members to engage in valuable academic and cultural exchanges.

Khumalo was an early beneficiary of this partnership and spent four months in Freiburg, immersing herself in the vibrant academic and cultural landscape. "The opportunity to study at the University of Education Freiburg was a dream come true," Khumalo shared. "The university's reputation for innovative teaching methods and its commitment to fostering a diverse and inclusive learning environment were incredibly appealing."

This experience, coupled with her dedication and leadership, has prepared her for the challenges and opportunities that lie ahead in the AUSP. Her journey serves as an inspiration to fellow students, demonstrating that with dedication, passion, and a commitment to excellence, they can achieve their dreams and contribute to shaping a better future.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept